The US National Cancer Institute Expands Contract with GENEART by USD 0.8M
News Jul 01, 2008
The NIH are therefore increasing the order volume for the production of genes for the "Mammalian Gene Collection (MGC)" to a total of USD 2.7M in 2008.
More than 3,500 genes with an order volume of approximately USD 3.5M were produced by GENEART last year as part of the basic contract.
The National Cancer Institute uses the genes synthesized by GENEART to supplement the Mammalian Gene Collection - a comprehensive collection of genes from mice, rats, and humans, both for basic research and for applied medical research.
The genes that have been produced so far are composed of complex repeat motifs, they are quite large and for most part are rare transcripts. In order to produce the requested highly complex genes efficiently in high throughput, GENEART further advanced its synthesis processes and established new production techniques last year.
The DNA Shuffle: Barcoding Trick is Boost to RNA-SeqNews
SPLiT-seq is a new technology that can separate thousands of cells using innovative barcoding technology.READ MORE
Comments | 0 ADD COMMENT
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
World Congress on Advances in Addiction Science and Medicine
Sep 24 - Sep 25, 2018
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018